MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-27-0066009
Aprowin Pharmaceuticals Private Limited
Aprowin Pharmaceuticals Private Limited - pharma in Raigarh, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹10.85 Lakh
▼ 11% YoY
Net profit · FY 2025
₹185
Net margin 0%
EBITDA · FY 2025
₹52,259
EBITDA margin 4.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Aprowin Pharmaceuticals Private Limited
Data last updated:
Aprowin Pharmaceuticals Private Limited is a private limited company based in Raigarh, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 May 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24309MH2022PTC382940. Its GSTIN is 27AAXCA0206A1Z3 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Akshaykumar Jha and Shalini Jha.
Its last annual general meeting (AGM) was held on 03 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 302 Eight Kool Homes S No. B Devad Village Vichumbe New Panvel, Raigarh, Maharashtra, India – 410206.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.85 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹185 (net margin 0%) and EBITDA of ₹52,259 (EBITDA margin 4.8%).
Aprowin Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0066009).
Company details
CIN U24309MH2022PTC382940
Registration Number 382940
Incorporation Date 19 May 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 03 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-27-0066009
Key People
Akshaykumar Jha Director Shalini Jha Director Recognitions & Rankings of Aprowin Pharmaceuticals
Contact details
Aprowin Pharmaceuticals Private Limited's registered office is in Raigarh, Maharashtra.
- Registered AddressA – 302 Eight Kool Homes S No. B Devad Village Vichumbe New Panvel, Raigarh, Maharashtra, India – 410206
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Aprowin Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Aprowin Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Aprowin Pharmaceuticals Private Limited, buy the company report.
Financials of Aprowin Pharmaceuticals Private Limited
FY 2025 filings availableAprowin Pharmaceuticals Private Limited reported revenue of ₹10.85 Lakh (down 11% YoY) for FY 2025.
Revenue · FY 2025
₹10.85 Lakh ▼ 11%
Net profit · FY 2025
₹185 margin 0%
EBITDA · FY 2025
₹52,259 margin 4.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 11%
EBITDA CAGR growth
1 year
▲ 81%
Revenue fell 11% in the latest year. EBITDA rose 81% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹52,259 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹185 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 4.8% | ||
| Net Profit Margin | 0% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Aprowin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aprowin Pharmaceuticals Private Limited
Aprowin Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akshaykumar Jha | Director | 19 May 2022 | 4 Years 5 Months | Current |
| Shalini Jha | Director | 19 May 2022 | 4 Years 5 Months | Current |
Peer comparison
Aprowin Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wilymed Pharmaceuticals Private Limited | ₹10.91 Lakh (FY 2024) | 70.0% | Gurugram, Haryana, India | |||
| Medrocket Pharmaceuticals Private Limited | ₹10.86 Lakh (FY 2023) | -18.0% | Thanjavur, Tamil Nadu, India | |||
| Aprowin Pharmaceuticals Private Limitedthis company | ₹10.85 Lakh (FY 2025) | ₹185 | 0% | -11.0% | Raigarh, Maharashtra, India | |
| Sidian Pharmaceuticals Private Limited | ₹10.84 Lakh (FY 2025) | -38.0% | Faizabad, Uttar Pradesh, India |
To see the full peer comparison of Aprowin Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aprowin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aprowin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aprowin Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAXCA0206A1Z3 | Maharashtra | Active | 28 Jul 2022 |
To see the full GST registrations and return filing status of Aprowin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aprowin Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Akshaykumar Jha was appointed as Director on 19 May 2022.
AGM
Aprowin Pharmaceuticals Private Limited last Annual general meeting of members was held on 03 Sep 2025 as per latest MCA records.
Filing
Aprowin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Akshaykumar Jha was appointed as Director.
Appointed
Shalini Jha was appointed as Director.
Incorporation
19 May 2022
Aprowin Pharmaceuticals Private Limited was registered on 19 May 2022 with Roc Mumbai Ii & aged 4 years 5 months as per MCA records.
Frequently asked questions
Aprowin Pharmaceuticals is an active private limited company based in Raigarh, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 May 2022 (4+ years old) and is registered under CIN U24309MH2022PTC382940.
Aprowin Pharmaceuticals has 2 current directors:
- Akshaykumar Jha - Director
- Shalini Jha - Director
The latest financial statements of Aprowin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 03 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Aprowin Pharmaceuticals is 27AAXCA0206A1Z3, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aprowin Pharmaceuticals is U24309MH2022PTC382940. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aprowin Pharmaceuticals was incorporated on 19 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Aprowin Pharmaceuticals by revenue are Wilymed Pharmaceuticals Private Limited, Medrocket Pharmaceuticals Private Limited, Sidian Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).
Akshaykumar Jha was appointed as Director on 19 May 2022. Shalini Jha was appointed as Director on 19 May 2022.
Yes, Aprowin Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-27-0066009).
The registered office of Aprowin Pharmaceuticals is at A – 302 Eight Kool Homes S No. B Devad Village Vichumbe New Panvel, Raigarh, Maharashtra, India – 410206.
Aprowin Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages